Mead Johnson Nutrition has sold its US$1.5bn debt in a three-part sale, the company said on Friday (30 October).
Go deeper with GlobalData
The offering included $500m of 3.50% notes due 2014 priced at 99.552% of the principal amount and $700m of 4.90% notes due 2019 priced at 99.649% of the principal amount.
It also included $300m of 5.90% notes due 2039 priced at 99.973% of the principal amount.
Proceeds from the offering are intended to be used to repay debt owed to a subsidiary of Bristol-Myers Squibb Company.
The sale of the notes is expected to close on or about 5 November, the company said.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
